// App-Quantinova.ai

1045 : The Potential Value of a Shared Decision-Making Intervention for Choices Regarding Triple Therapy in Rheumatoid Arthritis

Researchers

Presenter

  • Nick Bansback

Principal Investigators

  • Tima Mohammadi

  • Aslam Anis

  • James R. O'Dell

  • Glen Hazlewood

Medical Centers

  • School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

  • Center forHealth Evaluation and Outcomes Sciences, Vancouver, BC, Canada

  • University of British Columbia School of Population and Public Health, North Vancouver, BC, Canada

  • Department of Medicine, University of Nebraska Medical Center, Omaha, NE

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved